Blood Transfusion Diagnostics Market Forecast to 2028

Report Code : TIPRE00005176 | Region : Global | Industry : Medical Device | Published Date : 27/Jul/2022
Blood Transfusion Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Instruments & Kits and Reagents), Application (Disease Screening and Blood Grouping), and End User (Hospitals, Diagnostic Laboratories, and Plasma Fractionation Companies)

The global blood transfusion diagnostics market is expected to grow from US$ 4,096.93 million in 2021 to US$ 6,483.75 million by 2028. It is estimated to grow at a CAGR of 6.9% from 2022 to 2028. The report highlights prevailing trends and factors driving the market growth.

The growth of the global blood transfusion diagnostics market is attributed to the rapid increase in chronic diseases and the need for blood transfusion due to the rise in organ transplant surgeries. However, the problems associated with blood transfusion services hinder the overall market growth.

Blood transfusion diagnostics refers to tests performed on blood and blood components before they are transfused to patients. A blood transfusion is a common procedure in which donated blood or blood components are transfused into the patient's body through an intravenous line (IV). Each unit of blood must undergo blood typing, which refers to identification of blood type and blood screening, including disease detection tests to avoid side effects or transmission of infection. Blood screening before transfusion is performed through instruments, kits, and reagents to identify various diseases, such as HIV, hepatitis B, hepatitis C, Zika, and different viruses and infections.

According to the data published by the National Institute of Cancer Prevention and Research (NICPR) and the Indian Council of Medical Research (ICMR), the yearly prevalence of cancer in India is estimated at ~2.25 million, leading to numerous surgical procedures.

As per a 2019 study, titled "Challenges of blood transfusions in β-thalassemia," approximately 26,000 patients with transfusion-dependent β-thalassemia (TDT) are born every year, and around 90% of these births occur in low- or middle-income countries. Hemoglobinopathies, comprising sickle cell disease, are endemic in Africa, Asia, the Middle East, the Indian subcontinent, and the Mediterranean region. They are currently the most common rare inherited genetic diseases in Europe. Due to migration, hemoglobinopathies have been increasingly common in parts of North America and Northern and Western Europe, where they are not indigenous, and in their indigenous countries of Southern Europe. This led to an increase in the prevalence of β-thalassemia. Approximately 800 patients with thalassemia are registered in the UK National Haemoglobinopathy Registry, with around 500 patients undergoing regular blood transfusions. Therefore, blood transfusion diagnostics are widely used in various surgical procedures, such as cardiac surgery and other invasive procedures.

Chronic diseases, such as cancer, cardiovascular diseases, and renal disorders, are major causes of human death worldwide. These conditions are generally treated via surgical procedures, which are associated with a chance of excessive blood loss. Fresh blood is infused into patients to maintain their blood levels. Blood transfusion diagnostics are used during the blood infusion or reinfusion processes. Hence, the global blood transfusion diagnostics market is rising with the rapid increase in chronic diseases.

Based on product, the global blood transfusion diagnostics market is bifurcated into instruments & kits and reagents. In 2021, the instruments & kits segment held a larger market share. The same segment is expected to register a higher CAGR in the market from 2022 to 2028. Based on application, the market is bifurcated into disease screening and blood grouping. The disease screening segment held a larger market share in 2021 and is expected to register a higher CAGR during the forecast period. Based on end user, the market is segmented into blood banks, hospitals, diagnostic laboratories, and plasma fractionation companies. The blood banks segment held the largest market share in 2021. The same segment is expected to register the highest CAGR in the global blood transfusion diagnostics market from 2022 to 2028.

Impact of COVID-19 Pandemic on Global Blood Transfusion Diagnostics Market

The COVID-19 pandemic negatively impacted blood services operations worldwide. Blood collection was affected due to the decrease in donor availability caused by avoidance of public places, social distancing policies, and cancellation of blood drives. The negative impact on blood collection led to a reduction in blood transfusion due to insufficient blood supply. For instance, a research conducted by RMIT University, Australia, titled "The Impact of COVID-19 on Blood Transfusion Services: A Systematic Review and Meta-Analysis," revealed that the average decrease in blood donations was found to be 38% in the country. To cope with the blood shortage, campaigns were implemented to appeal for blood donation, raise public awareness about the importance of blood donation, and gain donors' confidence in safe blood donation. For instance, upon Korean Red Cross Blood Services' (KRCBS) request, the Ministry of Health and Welfare (MoHW) approved the relaxation of the geographical restrictions regarding indigenous malaria, thus enabling the collection of more than 23,000 units of whole blood.

Furthermore, doctors took the initiative to control unnecessary blood transfusions. For instance, according to the news published by ABC Science, in March 2022, Australian doctors warned against unnecessary blood transfusions in Australian hospitals. Also, as medical and surgical practices were restricted, the need for blood transfusions was decreased too. Thus, the above factors and instances indicate that the blood transfusion diagnostic market witnessed a negative COVID-19 impact.

Various organic and inorganic strategies are adopted by companies operating in the global blood transfusion diagnostics market. The organic strategies mainly include product launches and product approvals. Further, inorganic growth strategies witnessed in the market are acquisitions, collaborations, and partnerships. These growth strategies allow the market players to expand their businesses and enhance their geographic presence, thereby contributing to the overall market growth. Further, acquisition and partnership strategies help the market players strengthen their customer base and expand their product portfolios. A few significant developments by key players in the global blood transfusion diagnostics market are listed below.

• In July 2022, Quotient Limited announced an agreement with InfYnity Biomarkers, an R&D firm dedicated to utilizing biomarkers for managing infectious and immunology diseases. The two companies will partner to advance the safety and effectiveness of infectious disease testing by leveraging Quotient's MosaiQ solution.

• In November 2021, Roche announced the launch of the cobas 5800 System, a new molecular laboratory instrument, in countries accepting the CE mark. The cobas 5800 System helps address challenges that laboratories are facing from increased patient testing, reimbursement complexities, and the need for a more diverse testing menu while providing meaningful and timely results.

While preparing the report on the global blood transfusion diagnostics market, a few major primary and secondary sources are the National Health and Medical Research Council (NHMRC), the Government of Canada, and the Kidney Research and Clinical Practice (KRCP).

The List of Companies - Blood Transfusion Diagnostics Market

1. Grifols, S.A.

2. F. Hoffmann-La Roche Ltd

3. Immucor, Inc.

4. Bio-Rad Laboratories Inc.

5. Abbott

6. Thermo Fisher Scientific Inc.

7. Ortho Clinical Diagnostics

8. DiaSorin S.p.A.

9. Quotient Limited

10. BAG Diagnostics GmbH

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Global Blood Transfusion Diagnostics Market – By Product

1.3.2 Global Blood Transfusion Diagnostics Market – By Application

1.3.3 Global Blood Transfusion Diagnostics Market – By End User

1.3.4 Global Blood Transfusion Diagnostics Market – By Geography

2. Blood Transfusion Diagnostics Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Blood Transfusion Diagnostics Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 North America PEST Analysis

4.2.2 Europe PEST Analysis

4.2.3 Asia Pacific PEST Analysis

4.2.4 Middle East & Africa PEST Analysis

4.2.5 South & Central America PEST Analysis

4.3 Experts Opinion

5. Blood Transfusion Diagnostics Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Rapid Increase in Chronic Diseases

5.1.2 Need For Blood Transfusion due to Rise in Organ Transplants Surgeries

5.2 Market Restraints

5.2.1 Problems associated with Blood Transfusion Services

5.3 Market Opportunities

5.3.1 Elevated Healthcare Expenditure in Emerging Economies

5.3.2 Growing Initiatives by Governments

5.4 Future Trends

5.4.1 Technological Developments in Blood Transfusion Diagnostics

5.5 Impact Analysis

6. Blood Transfusion Diagnostics Market– Global Analysis

6.1 Global Blood Transfusion Diagnostics Market Revenue Forecast and Analysis

6.1.1 Global Blood Transfusion Diagnostics Market Revenue Forecast and Analysis

6.1.2 Global Blood Transfusion Diagnostics Market – Market Potential Analysis, By Region

6.2 Market Share Analysis of Key Players in Blood Transfusion Diagnostics Market

6.2.1 Company Analysis

6.2.2 Growth Strategy Analysis

6.2.3 Performance of Key Players

6.2.3.1 Grifols S.A.

6.2.3.2 F. Hoffmann-La Roche Ltd

7. Blood Transfusion Diagnostics Market Analysis and Forecasts To 2028 – By Product

7.1 Overview

7.2 Blood Transfusion Diagnostics Market Revenue Share, by Product (2021 and 2028)

7.3 Instruments and Kits

7.3.1 Overview

7.3.2 Instruments and Kits: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

7.4 Reagents

7.4.1 Overview

7.4.2 Reagents: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

8. Blood Transfusion Diagnostics Market Analysis – By Application

8.1 Overview

8.2 Blood Transfusion Diagnostics Market Revenue Share, by Application (2021 and 2028)

8.3 Disease Screening

8.3.1 Overview

8.3.2 Disease Screening: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

8.4 Blood Grouping

8.4.1 Overview

8.4.2 Blood Grouping: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

9. Blood Transfusion Diagnostics Market Analysis – By End User

9.1 Overview

9.2 Blood Transfusion Diagnostics Market Share, by End User, 2021 and 2028, (%)

9.3 Blood Banks

9.3.1 Overview

9.3.2 Blood Banks: Blood Transfusion Diagnostics Market, Revenue and Forecast to 2028 (US$ Million)

9.4 Hospitals

9.4.1 Overview

9.4.2 Hospitals: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

9.5 Diagnostic Laboratories

9.5.1 Overview

9.5.2 Diagnostic Laboratories: Blood Transfusion Diagnostics Market, Revenue and Forecast to 2028 (US$ Million)

9.6 Plasma Fractionation Companies

9.6.1 Overview

9.6.2 Plasma Fractionation Companies: Blood Transfusion Diagnostics Market, Revenue and Forecast to 2028 (US$ Million)

10. Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 – Geographical Analysis

10.1 North America: Blood Transfusion Diagnostics Market

10.1.1 Overview

10.1.2 North America: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.3 North America: Blood Transfusion Diagnostics Market, by Product, 2019–2028 (USD Million)

10.1.4 North America: Blood Transfusion Diagnostics Market, by Application, 2019–2028 (USD Million)

10.1.5 North America: Blood Transfusion Diagnostics Market, by End User, 2019–2028 (USD Million)

10.1.6 North America: Blood Transfusion Diagnostics Market, by Country, 2021 & 2028 (%)

10.1.6.1 US: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.6.1.1 US: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.6.1.2 US: Blood Transfusion Diagnostics Market, by Product, 2019–2028 (USD Million)

10.1.6.1.3 US: Blood Transfusion Diagnostics Market, by Application, 2019–2028 (USD Million)

10.1.6.1.4 US: Blood Transfusion Diagnostics Market, by End User, 2019–2028 (USD Million)

10.1.6.2 Canada: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.6.2.1 Canada: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.6.2.2 Canada: Blood Transfusion Diagnostics Market, by Product, 2019–2028 (USD Million)

10.1.6.2.3 Canada: Blood Transfusion Diagnostics Market, by Application, 2019–2028 (USD Million)

10.1.6.2.4 Canada: Blood Transfusion Diagnostics Market, by End User, 2019–2028 (USD Million)

10.1.6.3 Mexico: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.6.3.1 Mexico: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.6.3.2 Mexico: Blood Transfusion Diagnostics Market, by Product, 2019–2028 (USD Million)

10.1.6.3.3 Mexico: Blood Transfusion Diagnostics Market, by Application, 2019–2028 (USD Million)

10.1.6.3.4 Mexico: Blood Transfusion Diagnostics Market, by End User, 2019–2028 (USD Million)

10.2 Europe: Blood Transfusion Diagnostics Market

10.2.1 Overview

10.2.2 Europe: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)

10.2.3 Europe: Blood Transfusion Diagnostics Market, by Product, 2019–2028 (USD Million)

10.2.4 Europe: Blood Transfusion Diagnostics Market, by Application, 2019–2028 (USD Million)

10.2.5 Europe: Blood Transfusion Diagnostics Market, by End User, 2019–2028 (USD Million)

10.2.6 Europe: Blood Transfusion Diagnostics Market, by Country, 2021 & 2028 (%)

10.2.6.1 Germany: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.2.6.1.1 Germany: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.2.6.1.2 Germany: Blood Transfusion Diagnostics Market, by Product, 2019–2028 (USD Million)

10.2.6.1.3 Germany: Blood Transfusion Diagnostics Market, by Application, 2019–2028 (USD Million)

10.2.6.1.4 Germany: Blood Transfusion Diagnostics Market, by End User, 2019–2028 (USD Million)

10.2.6.2 UK: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.2.6.2.1 UK: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.2.6.2.2 UK: Blood Transfusion Diagnostics Market, by Product, 2019–2028 (USD Million)

10.2.6.2.3 UK: Blood Transfusion Diagnostics Market, by Application, 2019–2028 (USD Million)

10.2.6.2.4 UK: Blood Transfusion Diagnostics Market, by End User, 2019–2028 (USD Million)

10.2.6.3 France: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.2.6.3.1 France: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.2.6.3.2 France: Blood Transfusion Diagnostics Market, by Product, 2019–2028 (USD Million)

10.2.6.3.3 France: Blood Transfusion Diagnostics Market, by Application, 2019–2028 (USD Million)

10.2.6.3.4 France: Blood Transfusion Diagnostics Market, by End User, 2019–2028 (USD Million)

10.2.6.4 Italy: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.2.6.4.1 Italy: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.2.6.4.2 Italy: Blood Transfusion Diagnostics Market, by Product, 2019–2028 (USD Million)

10.2.6.4.3 Italy: Blood Transfusion Diagnostics Market, by Application, 2019–2028 (USD Million)

10.2.6.4.4 Italy: Blood Transfusion Diagnostics Market, by End User, 2019–2028 (USD Million)

10.2.6.5 Spain: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.2.6.5.1 Spain: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.2.6.5.2 Spain: Blood Transfusion Diagnostics Market, by Product, 2019–2028 (USD Million)

10.2.6.5.3 Spain: Blood Transfusion Diagnostics Market, by Application, 2019–2028 (USD Million)

10.2.6.5.4 Spain: Blood Transfusion Diagnostics Market, by End User, 2019–2028 (USD Million)

10.2.6.6 Rest of Europe: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.2.6.6.1 Rest of Europe: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.2.6.6.2 Rest of Europe: Blood Transfusion Diagnostics Market, by Product, 2019–2028 (USD Million)

10.2.6.6.3 Rest of Europe: Blood Transfusion Diagnostics Market, by Application, 2019–2028 (USD Million)

10.2.6.6.4 Rest of Europe: Blood Transfusion Diagnostics Market, by End User, 2019–2028 (USD Million)

10.3 Asia Pacific Blood Transfusion Diagnostics Market Revenue and Forecasts To 2028

10.3.1 Overview

10.3.2 Asia Pacific Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

10.3.3 Asia Pacific: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

10.3.4 Asia Pacific: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)

10.3.5 Asia Pacific: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)

10.3.6 Asia Pacific: Blood Transfusion Diagnostics Market, by Country, 2021 & 2028 (%)

10.3.6.1 China: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

10.3.6.1.1 Overview

10.3.6.1.2 China: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

10.3.6.1.3 China: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

10.3.6.1.4 China: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)

10.3.6.1.5 China: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)

10.3.6.2 Japan: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

10.3.6.2.1 Overview

10.3.6.2.2 Japan: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

10.3.6.2.3 Japan: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

10.3.6.2.4 Japan: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)

10.3.6.2.5 Japan: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)

10.3.6.3 India Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

10.3.6.3.1 Overview

10.3.6.3.2 India: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

10.3.6.3.3 India: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

10.3.6.3.4 India: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)

10.3.6.3.5 India: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)

10.3.6.4 South Korea: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

10.3.6.4.1 Overview

10.3.6.4.2 South Korea: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

10.3.6.4.3 South Korea: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

10.3.6.4.4 South Korea: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)

10.3.6.4.5 South Korea: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)

10.3.6.5 Australia: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

10.3.6.5.1 Overview

10.3.6.5.2 Australia: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

10.3.6.5.3 Australia: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

10.3.6.5.4 Australia: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)

10.3.6.5.5 Australia: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)

10.3.6.6 Rest of Asia Pacific: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.3.6.6.1 Overview

10.3.6.6.2 Rest of Asia Pacific: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.3.6.6.3 Rest of Asia Pacific: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

10.3.6.6.4 Rest of Asia Pacific: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)

10.3.6.6.5 Rest of Asia Pacific: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)

10.4 South and Central America Blood Transfusion Diagnostics Market

10.4.1 Overview

10.4.2 South and Central America Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

10.4.3 South and Central America Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

10.4.4 South and Central America: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)

10.4.5 South and Central America: Blood Transfusion Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.4.6 South and Central America: Blood Transfusion Diagnostics Market, by Country, 2021 & 2028 (%)

10.4.6.1 Brazil: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.4.6.1.1 Overview

10.4.6.1.2 Brazil Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

10.4.6.1.3 Brazil: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

10.4.6.1.4 Brazil: Blood Transfusion Diagnostics Market Revenue and Forecasts To 2028, By Application (US$ Million)

10.4.6.1.5 Brazil: Blood Transfusion Diagnostics Market Revenue and Forecasts To 2028, By End User (US$ Million)

10.4.6.2 Argentina: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.4.6.2.1 Overview

10.4.6.2.2 Argentina Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

10.4.6.2.3 Argentina: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

10.4.6.2.4 Argentina: Blood Transfusion Diagnostics Market Revenue and Forecasts To 2028, By Application (US$ Million)

10.4.6.2.5 Argentina: Blood Transfusion Diagnostics Market Revenue and Forecasts To 2028, By End User (US$ Million)

10.4.6.3 Rest of the South and Central America: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.4.6.3.1 Overview

10.4.6.3.2 Rest of the South and Central America Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

10.4.6.3.3 Rest of South & Central America: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

10.4.6.3.4 Rest of South & Central America: Blood Transfusion Diagnostics Market Revenue and Forecasts To 2028, By Application (US$ Million)

10.4.6.3.5 Rest of South & Central America: Blood Transfusion Diagnostics Market Revenue and Forecasts To 2028, By End User (US$ Million)

10.5 Middle East & Africa Blood Transfusion Diagnostics Market

10.5.1 Overview

10.5.2 Middle East & Africa Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

10.5.3 Middle East & Africa: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

10.5.4 Middle East & Africa: Metabolomics Market Revenue and Forecasts to 2028, By Application (US$ Million)

10.5.5 Middle East & Africa: Blood Transfusion Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.5.6 Middle East & Africa: Blood Transfusion Diagnostics Market, by Country, 2021 & 2028 (%)

10.5.6.1 South Africa: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.5.6.1.1 Overview

10.5.6.1.2 South Africa Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

10.5.6.1.3 South Africa: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

10.5.6.1.4 South Africa: Metabolomics Market Revenue and Forecasts To 2028, By Application (US$ Million)

10.5.6.1.5 South Africa: Metabolomics Market Revenue and Forecasts To 2028, By End User (US$ Million)

10.5.6.2 Saudi Arabia: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.5.6.2.1 Overview

10.5.6.2.2 Saudi Arabia Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

10.5.6.2.3 Saudi Arabia: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

10.5.6.2.4 Saudi Arabia: Blood Transfusion Diagnostics Market Revenue and Forecasts To 2028, By Application (US$ Million)

10.5.6.2.5 Saudi Arabia: Blood Transfusion Diagnostics Market Revenue and Forecasts To 2028, By End User (US$ Million)

10.5.6.3 UAE: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.5.6.3.1 Overview

10.5.6.3.2 UAE: Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

10.5.6.3.3 UAE: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

10.5.6.3.4 UAE: Blood Transfusion Diagnostics Market Revenue and Forecasts To 2028, By Application (US$ Million)

10.5.6.3.5 UAE: Blood Transfusion Diagnostics Market Revenue and Forecasts To 2028, By End User (US$ Million)

10.5.6.4 Rest of the Middle East and Africa: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.5.6.4.1 Overview

10.5.6.4.2 Rest of the Middle East and Africa Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

10.5.6.4.3 Rest of Middle East & Africa: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

10.5.6.4.4 Rest of Middle East & Africa: Metabolomics Market Revenue and Forecasts To 2028, By Application (US$ Million)

10.5.6.4.5 Rest of Middle East & Africa: Metabolomics Market Revenue and Forecasts To 2028, By End User (US$ Million)

11. Impact of COVID-19 Pandemic on Blood Transfusion Diagnostics Market

11.1 North America: Impact Assessment of COVID-19 Pandemic

11.2 Europe: Impact Assessment of COVID-19 Pandemic

11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic

11.4 South and Central America: Impact Assessment of COVID-19 Pandemic

11.5 Middle East and Africa: Impact Assessment of COVID-19 Pandemic

12. Blood Transfusion Diagnostics Market–Industry Landscape

12.1 Overview

12.2 Growth Strategies in the Blood Transfusion Diagnostics Market

12.3 Inorganic Growth Strategies

12.3.1 Overview

12.4 Organic Growth Strategies

12.4.1 Overview

13. Company Profiles

13.1 Grifols, S.A.

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 F. Hoffmann-La Roche Ltd

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 Immucor, Inc.

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Bio-Rad Laboratories, Inc.

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 Abbott

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Thermo Fisher Scientific Inc.

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Ortho Clinical Diagnostics (QuidelOrtho Corporation)

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 DiaSorin S.p.A.

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 Quotient Limited

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

13.10 BAG Diagnostics GmbH

13.10.1 Key Facts

13.10.2 Business Description

13.10.3 Products and Services

13.10.4 Financial Overview

13.10.5 SWOT Analysis

13.10.6 Key Developments

14. Appendix

14.1 About The Insight Partners

14.2 Glossary of Terms

LIST OF TABLES.

Table 1. North America: Blood Transfusion Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 2. North America: Blood Transfusion Diagnostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 3. North America: Blood Transfusion Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 4. US: Blood Transfusion Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 5. US: Blood Transfusion Diagnostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 6. US: Blood Transfusion Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 7. Canada: Blood Transfusion Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 8. Canada: Blood Transfusion Diagnostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 9. Canada: Blood Transfusion Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 10. Mexico: Blood Transfusion Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 11. Mexico: Blood Transfusion Diagnostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 12. Mexico: Blood Transfusion Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 13. Europe: Blood Transfusion Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 14. Europe: Blood Transfusion Diagnostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 15. Europe: Blood Transfusion Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 16. Germany: Blood Transfusion Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 17. Germany: Blood Transfusion Diagnostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 18. Germany: Blood Transfusion Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 19. UK: Blood Transfusion Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 20. UK: Blood Transfusion Diagnostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 21. UK: Blood Transfusion Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 22. France: Blood Transfusion Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 23. France: Blood Transfusion Diagnostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 24. France: Blood Transfusion Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 25. Italy: Blood Transfusion Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 26. Italy: Blood Transfusion Diagnostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 27. Italy: Blood Transfusion Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 28. Spain: Blood Transfusion Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 29. Spain: Blood Transfusion Diagnostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 30. Spain: Blood Transfusion Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 31. Rest of Europe: Blood Transfusion Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 32. Rest of Europe: Blood Transfusion Diagnostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 33. Rest of Europe: Blood Transfusion Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 34. Asia Pacific: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million).

Table 35. Asia Pacific: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 36. Asia Pacific: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)

Table 37. China: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

Table 38. China: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 39. China: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)

Table 40. Japan: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

Table 41. Japan: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 42. Japan: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)

Table 43. India: National Estimation of Blood Requirement in India (2018)

Table 44. India: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

Table 45. India: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 46. India: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)

Table 47. South Korea: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

Table 48. South Korea: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 49. South Korea: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)

Table 50. Australia: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

Table 51. Australia: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 52. Australia: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)

Table 53. Rest of Asia Pacific: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

Table 54. Rest of Asia Pacific: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 55. Rest of Asia Pacific: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)

Table 56. South and Central America Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

Table 57. South and Central America: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 58. South and Central America: Blood Transfusion Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 59. Brazil: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

Table 60. Brazil: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 61. Brazil: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)

Table 62. Argentina: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

Table 63. Argentina: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 64. Argentina: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)

Table 65. Rest of South & Central America: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

Table 66. Rest of South & Central America: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 67. Rest of South & Central America: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)

Table 68. Middle East & Africa: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

Table 69. Middle East & Africa: Metabolomics Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 70. Middle East & Africa: Blood Transfusion Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 71. South Africa Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

Table 72. South Africa: Metabolomics Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 73. South Africa: Metabolomics Market Revenue and Forecasts to 2028, By End User (US$ Million)

Table 74. Saudi Arabia: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

Table 75. Saudi Arabia: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 76. Saudi Arabia: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)

Table 77. UAE: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

Table 78. UAE: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 79. UAE: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)

Table 80. Rest of Middle East & Africa: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

Table 81. Rest of Middle East & Africa: Metabolomics Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 82. Rest of Middle East & Africa: Metabolomics Market Revenue and Forecasts to 2028, By End User (US$ Million)

Table 83. Recent Inorganic Growth Strategies in the Blood Transfusion Diagnostics Market

Table 84. Recent Organic Growth Strategies in the Blood Transfusion Diagnostics Market

Table 85. Glossary of Terms

The List of Companies - Blood Transfusion Diagnostics Market

1. Grifols, S.A.

2. F. Hoffmann-La Roche Ltd

3. Immucor, Inc.

4. Bio-Rad Laboratories Inc.

5. Abbott

6. Thermo Fisher Scientific Inc.

7. Ortho Clinical Diagnostics

8. DiaSorin S.p.A.

9. Quotient Limited

10. BAG Diagnostics GmbH

Reason To Buy

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the blood transfusion diagnostics market.

● Highlights key business priorities in order to assist companies to realign their business strategies.

● The key findings and recommendations highlight crucial progressive industry trends in the blood transfusion diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies.

● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

● Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

● Enhancing the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

AVAILABLE CUSTOMIZATION RESEARCH METHODOLOGY REQUEST FOR TOC FREE SAMPLE REPORT
CHOOSE LICENCE TYPE
(Blood Transfusion Diagnostics Market Forecast to 2028 )
  • Single User Price $4,550$3,640
  • Site Price $6,550$5,240
  • Enterprise Price $8,550$6,840
Buy Now Add to Cart
REQUEST FOR TOC
SPEAK TO ANALYST
FREE SAMPLE
REPORT
INQUIRE BEFORE
BUYING
TOP
Quick Enquiry